BMJ  2007;334:982 (12 May), doi:10.1136/bmj.39202.399942.AD

Feature

Head to head

Should women be offered cholesterol lowering drugs to prevent cardiovascular disease? Yes

Scott M Grundy, professor

Center for Human Nutrition, Departments of Clinical Nutrition and Internal Medicine, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9052, USA

scott.grundy@utsouthwestern.edu

Women in western countries are more likely to die from heart disease than from cancer. Scott M Grundy argues that the risks make preventive treatment essential, but Malcolm Kendrick believes the evidence of benefit is not strong enough

The first 150 words of the full text of this article appear below.

Primary and secondary trials show that cholesterol lowering drugs reduce the risk of cardiovascular disease events in men.1 2 Secondary prevention trials in women with established cardiovascular disease also show a reduction in risk.3 4 5 Meta-analyses also show that when all women with or without cardiovascular disease are combined, cholesterol lowering treatment produces benefit.6 7

Some investigators nevertheless argue that women without cardiovascular disease should not be given cholesterol lowering drugs because of insufficient evidence from primary prevention trials in women.8 They speculate that women with and without cardiovascular disease respond differently to the drugs; if true, women may not respond to treatment even when they have the same level of risk as men who do benefit.1 2 This speculation discounts prospective studies showing that raised cholesterol concentration is a major risk factor for first heart attack in both men and women.9

The pathological basis for a difference in response to cholesterol lowering therapy . . . [Full text of this article]

Level of risk


Acting on evidence


Related Articles

Testing common sense
Fiona Godlee
BMJ 2007 334: 0. [Extract] [Full Text]

Should women be offered cholesterol lowering drugs to prevent cardiovascular disease? No
Malcolm Kendrick
BMJ 2007 334: 983. [Extract] [Full Text] [PDF]

Rapid Responses:

Read all Rapid Responses

Should women be offered statin treatment? Certainly not!
Uffe Ravnskov
bmj.com, 11 May 2007 [Full text]
Why Statins Should Not Be Prescribed To Women
Paul J. Rosch
bmj.com, 12 May 2007 [Full text]
A sexy debate?
George Loucas Tzanis, et al.
bmj.com, 13 May 2007 [Full text]
Absence of Evidence or Evidence of Absence?
Peter R Bates
bmj.com, 14 May 2007 [Full text]
Thrombus: cause or consequence of myocardial infarction?
Carlos Monteiro
bmj.com, 15 May 2007 [Full text]
Why would anyone want low serum cholesterol?
Barry A Groves
bmj.com, 15 May 2007 [Full text]
Why categorically deny treatment?
Phillipa J Rispin
bmj.com, 15 May 2007 [Full text]
Re: Thrombus: cause or consequence of myocardial infarction?
Alejandro F. Luque-Coqui
bmj.com, 18 May 2007 [Full text]
Living off the fat of the land
Peter J Selley
bmj.com, 17 May 2007 [Full text]
Lets be FAIR to the FAIRER sex
Carolyn M Balaam
bmj.com, 18 May 2007 [Full text]
Re: Living off the fat of the land
Peter W Ward
bmj.com, 17 May 2007 [Full text]
Low dose Statins are effective in Post menopausal women for primary prevention of Coronary Heart Disease (CHD)
Professor Pranab Kumar Bhattacharya, et al.
bmj.com, 19 May 2007 [Full text]
Re: Re: Thrombus: cause or consequence of myocardial infarction?
Carlos Monteiro
bmj.com, 19 May 2007 [Full text]
Would you bet?
Luca Mascitelli
bmj.com, 20 May 2007 [Full text]



Student BMJ

Risk of surgery for inflammatory bowel disease: record linkage studies

What can you learn from this BMJ paper? Read Leanne Tite's Paper+

www.student.bmj.com

Listen to the latest BMJ Interview